SCHEMBL6563283

SCHEMBL6563283

CN(C)C(=O)c1ccc(C#CCNc2ccc(C(=N)NC(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 1/20 0.46
ACACB O00763 3/20 0.39
PTGES O14684 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.33
GPR119 Q8TDV5 1/20 0.33
ATR Q13535 1/20 0.33
ALDH1A1 P00352 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
EGLN1 Q9GZT9 1/20 0.32
EPHX2 P34913 1/20 0.32
NR1H4 Q96RI1 1/20 0.32
HPGD P15428 1/20 0.32
CYP17A1 P05093 1/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6561813 0.89 PTPN11 (0.42) PTPN11ACACBPTGESATR
SCHEMBL6563070 0.84 PTPN11 (0.44) PTPN11NR1H4CYP17A1
SCHEMBL6563355 0.84 PTPN11 (0.47) PTPN11PTGESCYP17A1
SCHEMBL6563526 0.83 PTPN11 (0.38) PTPN11ACACBPTGES
SCHEMBL6565352 0.82 PTPN11 (0.33) PTPN11
SCHEMBL7686729 0.82 PTPN11 (0.43) PTPN11ACACBALDH1A1SMN1; SMN2HPGD
SCHEMBL7674981 0.82 ABL1 (0.43) PTPN11ACACBALDH1A1SMN1; SMN2HPGD
SCHEMBL6561879 0.81 PTPN11 (0.38) PTPN11ACACBPTGESPTGDR2SMN1; SMN2
SCHEMBL6565434 0.81 PTPN11 (0.41) PTPN11PTGESMAPT
SCHEMBL6565384 0.81 GRM5 (0.46) PTPN11ACACBEGLN1EPHX2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140802-B1 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-03-17 EP disclosed
US-6479524-B1 TO PROLONG THE THROMBIN TIME BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-11-12 US disclosed